Browse > Article
http://dx.doi.org/10.5483/BMBRep.2017.50.2.150

Zinc(II) ion promotes anti-inflammatory effects of rhSOD3 by increasing cellular association  

Kim, Younghwa (Department of Emergency Medical Technology, Kyungil University)
Jeon, Yoon-Jae (Laboratory of Dermato-Immunology, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea)
Ryu, Kang (RNS BIO)
Kim, Tae-Yoon (Laboratory of Dermato-Immunology, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea)
Publication Information
BMB Reports / v.50, no.2, 2017 , pp. 85-90 More about this Journal
Abstract
Recently, we demonstrated that superoxide dismutase 3 (SOD3) is a strong candidate for biomedicine. Anti-oxidant function of SOD3 was accomplished without cell penetration, and it inhibited the inflammatory responses via non-enzymatic functions. SOD3 has the heparin binding domain associating cell surface. Interestingly, we found that $Zn^{2+}$ promotes transduction effects of recombinant human SOD3 (rhSOD3) by increasing uptake via the heparin binding domain (HBD). We demonstrated an uptake of rhSOD3 from media to cell lysate via HBD, resulting in an accumulation of rhSOD3 in the nucleus, which was promoted by the presence of $Zn^{2+}$. This resulted in increased inhibitory effects of rhSOD3 on NF-{\kappa}B and STAT3 signals in the presence of $Zn^{2+}$, which shows elevated association of rhSOD3 into the cells. These results suggest that an optimized procedure can help to enhance the inflammatory efficacy of rhSOD3, as a novel biomedicine.
Keywords
Anti-inflammatory; Cytopermeability; Heparin Binding Domain; Superoxide dismutase 3; Zinc (II) ion;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Serra V, von Zglinicki T, Lorenz M and Saretzki G (2003) Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 278, 6824-6830   DOI
2 Teoh ML, Fitzgerald MP, Oberley LW and Domann FE (2009) Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res 69, 6355-6363   DOI
3 Wheeler MD, Smutney OM and Samulski RJ (2003) Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice. Mol Cancer Res 1, 871-881
4 Laukkanen MO, Kivela A, Rissanen T et al (2002) Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloondenuded rabbit aorta. Circulation 106, 1999-2003   DOI
5 Marklund SL (1990) Expression of extracellular superoxide dismutase by human cell lines. Biochem J 266, 213-219   DOI
6 Marklund SL (1992) Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 267, 6696-6701
7 Stralin P and Marklund SL (2000) Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151, 433-441   DOI
8 Ookawara T, Kizaki T, Takayama E et al (2002) Nuclear translocation of extracellular superoxide dismutase. Biochem Biophys Res Commun 296, 54-61   DOI
9 Green M and Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188   DOI
10 Frankel AD and Pabo CO (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193   DOI
11 Dixon JE, Osman G, Morris GE et al (2016) Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proc Natl Acad Sci U S A 113, E291-299   DOI
12 Juul K, Tybjaerg-Hansen A, Marklund S, Lange P and Nordestgaard BG (2006) Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173, 858-864   DOI
13 Shrestha P, Yun JH, Kim WT, Kim TY and Lee W (2016) Cloning, purification, and characterization of recombinant human extracellular superoxide dismutase in SF9 insect cells. Mol Cells 39, 242-249   DOI
14 Park KY, Kim EY, Lee W, Kim TY and Kim WT (2016) Expression, subcellular localization, and enzyme activity of a recombinant human extra-cellular superoxide dismutase in tobacco (Nicotiana benthamiana L.). Protein Expr Purif 119, 69-74   DOI
15 Ryu K, Kim YH, Kim Y, Lee JS, Jeon B and Kim TY (2008) Increased yield of high-purity and active tetrameric recombinant human EC-SOD by solid phase refolding. J Microbiol Biotechnol 18, 1648-1654
16 Auten RL, O'Reilly MA, Oury TD, Nozik-Grayck E and Whorton MH (2006) Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol 290, L32-40   DOI
17 Gongora MC, Lob HE, Landmesser U et al (2008) Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol 173, 915-926   DOI
18 Oury TD, Day BJ and Crapo JD (1996) Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 20, 957-965   DOI
19 Kwon MJ, Jeon YJ, Lee KY and Kim TY (2012) Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxid Redox Signal 17, 1376-1392   DOI
20 Kim S, Kim HY, Kim JH et al (2015) Enhancement of potency and stability of human extracellular superoxide dismutase. BMB Rep 48, 91-96   DOI
21 Uematsu T, Nagashima S, Umemura K, Kanamaru M and Nakashima M (1994) Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase (NK341) in healthy subjects. Int J Clin Pharmacol Ther 32, 638-641
22 Kwon MJ, Han J, Kim BH, Lee YS and Kim TY (2012) Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. Antioxid Redox Signal 16, 297-313   DOI
23 Jeon B, Kim BH, Lee YS, Kim S, Yoon JB and Kim TY (2011) Inactive extracellular superoxide dismutase disrupts secretion and function of active extracellular superoxide dismutase. BMB Rep 44, 40-45   DOI
24 Kim Y, Kim BH, Lee H et al (2011) Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1a and NF-kB pathways. Free Radic Biol Med 51, 1985-1995   DOI